Inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis largely reversed the injurious effects of hyperoxia, resulting in attenuated lung inflammation, improved alveolarization and pulmonary vascular development, and alleviated pulmonary fibrosis. Here, GSDMD is linked to pulmonary fibrosis.